文献速递流行病学与生物统计医学人工智能与信息学

临床背景下「活」COVID-19登记库开发的方法学

The methodology of a "living" COVID-19 registry development in a clinical context.
PubMed 文献 · J Clin Epidemiol · 2021-11-14

该研究描述了一种持续更新的COVID-19登记库开发方法,始于2020年3月,在Fondazione Don Gnocchi多中心开展。通过整合活系统评价与焦点小组方法,建成包含520个字段、覆盖17个中心748例COVID-19患者的登记库。作者认为该登记库有助于识别风险特征和预测住院患者治疗成功,该方法学或可用于其他登记库建设。

要点

  • 整合活系统评价与焦点小组方法开发持续更新的COVID-19登记库。
  • 登记库含520个字段,覆盖17个中心748例COVID-19住院患者。
  • 作者认为该登记库有助于识别风险特征和预测住院患者治疗成功。

核心结论

  • 活COVID-19登记库提供开放、持续更新的大规模患者层面数据访问,作者认为可帮助识别重要因素和调节变量以识别风险特征并预测住院COVID-19患者的治疗成功。
  • 作者认为这一创新方法学或可用于其他登记库,以确保所收集数据是达成既定科学目标的适当手段。

研究设计与样本

  • 方法学研究设计,开发多中心、活的COVID-19登记库,纳入Fondazione Don Gnocchi中心收治的COVID-19患者,始于2020年3月。
  • 整合活系统评价与焦点小组方法学开发登记库。

主要发现

  • 登记库包含520个字段,为来自17个Fondazione Don Gnocchi中心的748例COVID-19患者填写。
  • 建成一个基于证据和经验的登记库,依据2020年3月疫情暴发前未知的新疾病的演变而更新。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to describe an innovative methodology of a registry development, constantly updated for the scientific assessment and analysis of the health status of the population with COVID-19. STUDY DESIGN AND SETTING: A methodological study design to develop a multi-site, Living COVID-19 Registry of COVID-19 patients admitted in Fondazione Don Gnocchi centres started in March 2020. RESULTS: The integration of the living systematic reviews and focus group methodologies led to a development of a registry which includes 520 fields filled in for 748 COVID-19 patients recruited from 17 Fondazione Don Gnocchi centres. The result is an evidence and experience-based registry, according to the evolution of a new pathology which was not known before outbreak of March 2020 and with the aim of building knowledge to provide a better quality of care for COVID-19 patients. CONCLUSION: A Living COVID-19 Registry is an open, living and up to date access to large-scale patient-level data sets that could help identifying important factors and modulating variable for recognising risk profiles and predicting treatment success in COVID-19 patients hospitalized. This innovative methodology might be used for other registries, to be sure which the data collected is an appropriate means of accomplishing the scientific objectives planned. CLINICAL TRIAL REGISTRATION NUMBER: not applicable.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Arienti C, Campagnini S, Brambilla L, et al. The methodology of a "living" COVID-19 registry development in a clinical context. J Clin Epidemiol. 2021. PMID: 34788655. doi:10.1016/j.jclinepi.2021.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。